Associated Papers
HDAC3 as an Emerging Therapeutic Target for Alzheimer's Disease and other Neurological Disorders.
Li Y et al.
Molecular Neurobiology, 2025
Enzyme-independent functions of HDAC3 in the adult heart.
Qian S et al.
Acta Pharmaceutica Sinica. B, 2025
Enzyme-independent functions of HDAC3 in the adult heart.
Qian S et al.
Biorxiv : the Preprint Server for Biology, 2024
De novo missense variants in HDAC3 leading to epigenetic machinery dysfunction are associated with a variable neurodevelopmental disorder.
Yoon JG et al.
American Journal of Human Genetics, 2024
Acetylation dependent translocation of EWSR1 regulates CHK2 alternative splicing in response to DNA damage.
Zhang T et al.
Oncogene, 2022
Genome-Nuclear Lamina Interactions Regulate Cardiac Stem Cell Lineage Restriction.
Poleshko A et al.
Cell, 2017
Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth.
Lin HP et al.
Cancer Research, 2016
Histone deacetylases: structural determinants of inhibitor selectivity.
Micelli C et al.
Drug Discovery Today, 2015
Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1.
Wang S et al.
Plos Biology, 2015
Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor.
Sun Z et al.
Molecular Cell, 2013
HDAC3 is a critical negative regulator of long-term memory formation.
McQuown SC et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2011
Select a paper to view details